Search results for "Immunization"
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
https://immattersacp.org/weekly/archives/2020/12/15/5.htm
15 Dec 2020
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
Anaphylaxis appears rare with COVID-19 vaccine, alternative administration strategies considered
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
https://immattersacp.org/weekly/archives/2021/01/12/2.htm
12 Jan 2021
More booster authorizations, research on vaccine safety and uptake
The FDA and CDC endorsed boosters of the Johnson & Johnson and Moderna vaccines. Recent research showed that COVID-19 vaccination was not associated with miscarriage, and a small financial incentive for receiving a COVID-19 vaccine or providing transportation to a vaccination site increased uptake.
https://immattersacp.org/weekly/archives/2021/10/26/1.htm
26 Oct 2021
MKSAP Quiz: Routine visit for a patient with chronic kidney disease
A 45-year-old man is evaluated during a routine visit in September. He has advanced chronic kidney disease due to IgA nephropathy. After his vaccination history is evaluated, what is the most appropriate additional vaccine to administer at this visit?
https://immattersacp.org/weekly/archives/2023/07/18/3.htm
18 Jul 2023
New data on COVID-19 vaccines' effectiveness over time, boosters, barriers to uptake
Multiple recent studies assessed the effectiveness of the COVID-19 vaccines at different time intervals after vaccination, while others looked at the impact of booster shots. Results of a survey suggested that racial differences in vaccine uptake may be attributable to social barriers.
https://immattersacp.org/weekly/archives/2021/12/07/1.htm
7 Dec 2021
Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk
Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
Q&A: Dealing with COVID-19 vaccine allocation, distribution
The new availability of vaccines has highlighted the challenges of allocation and distribution, which were the focus of a recent forum hosted by ACP and Annals of Internal Medicine.
https://immattersacp.org/weekly/archives/2021/02/02/2.htm
2 Feb 2021
ACP offers free webinars on immunization on Aug. 23, Sept. 12, Sept. 23
Upcoming webinars for National Immunization Awareness Month will cover resident education, immunization in HIV, and development of a vaccination program.
https://immattersacp.org/weekly/archives/2019/08/20/5.htm
20 Aug 2019